Table 1.
Proportions of clinical characteristics in Dataset1 and Dataset2, Figure 2.
Histology and TNM stage were based on pathology were available.
| Dataset1 | Dataset2 | |
|---|---|---|
| Gender | ||
| Male | 100 (45%) | 59 (68%) |
| Female | 124 (55%) | 28 (32%) |
| Histology | ||
| Adenocarcinoma | 129 (58%) | 42 (48%) |
| Squamous | 61 (27%) | 33 (38%) |
| Other | 34 (15%) | 12 (14%) |
| Stage | ||
| I | 123 (55%) | 39 (45%) |
| II | 35 (15%) | 26 (30%) |
| III | 46 (21%) | 12 (14%) |
| Other | 20 (9%) | 10 (11%) |
| Smoking Status | ||
| Current | 66 (29%) | NA |
| Former | 141 (63%) | NA |
| None | 17 (8%) | NA |
| Tumor site | ||
| Primary | 224 (100%) | 87 (100%) |
| Endpoints | ||
| Overall survivals | 134 (60%) | 41 (47%) |
| Overall deaths | 90 (40%) | 46 (53%) |
| Follow up (median months) |
32 | 31 |